| Product Code: ETC12835951 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Infectious Disease Drugs Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Infectious Disease Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Infectious Disease Drugs Market - Industry Life Cycle |
3.4 Israel Infectious Disease Drugs Market - Porter's Five Forces |
3.5 Israel Infectious Disease Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Israel Infectious Disease Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Infectious Disease Drugs Market Revenues & Volume Share, By End-Use, 2021 & 2031F |
3.8 Israel Infectious Disease Drugs Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
4 Israel Infectious Disease Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Israel |
4.2.2 Growing investments in research and development of new drugs |
4.2.3 Rising awareness about the importance of early diagnosis and treatment of infectious diseases |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 High cost associated with developing and manufacturing infectious disease drugs |
4.3.3 Limited access to healthcare facilities in certain regions of Israel |
5 Israel Infectious Disease Drugs Market Trends |
6 Israel Infectious Disease Drugs Market, By Types |
6.1 Israel Infectious Disease Drugs Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Infectious Disease Drugs Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Israel Infectious Disease Drugs Market Revenues & Volume, By Antiviral, 2021 - 2031F |
6.1.4 Israel Infectious Disease Drugs Market Revenues & Volume, By Antibiotic, 2021 - 2031F |
6.1.5 Israel Infectious Disease Drugs Market Revenues & Volume, By Antifungal, 2021 - 2031F |
6.2 Israel Infectious Disease Drugs Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Infectious Disease Drugs Market Revenues & Volume, By Respiratory Infections, 2021 - 2031F |
6.2.3 Israel Infectious Disease Drugs Market Revenues & Volume, By Gastrointestinal Infections, 2021 - 2031F |
6.2.4 Israel Infectious Disease Drugs Market Revenues & Volume, By Bloodborne Infections, 2021 - 2031F |
6.3 Israel Infectious Disease Drugs Market, By End-Use |
6.3.1 Overview and Analysis |
6.3.2 Israel Infectious Disease Drugs Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Israel Infectious Disease Drugs Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.3.4 Israel Infectious Disease Drugs Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4 Israel Infectious Disease Drugs Market, By Mode of Administration |
6.4.1 Overview and Analysis |
6.4.2 Israel Infectious Disease Drugs Market Revenues & Volume, By Oral, 2021 - 2031F |
6.4.3 Israel Infectious Disease Drugs Market Revenues & Volume, By Injectable, 2021 - 2031F |
7 Israel Infectious Disease Drugs Market Import-Export Trade Statistics |
7.1 Israel Infectious Disease Drugs Market Export to Major Countries |
7.2 Israel Infectious Disease Drugs Market Imports from Major Countries |
8 Israel Infectious Disease Drugs Market Key Performance Indicators |
8.1 Number of clinical trials conducted for new infectious disease drugs |
8.2 Percentage of population vaccinated against common infectious diseases |
8.3 Rate of adoption of innovative treatment methods for infectious diseases |
9 Israel Infectious Disease Drugs Market - Opportunity Assessment |
9.1 Israel Infectious Disease Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Israel Infectious Disease Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Infectious Disease Drugs Market Opportunity Assessment, By End-Use, 2021 & 2031F |
9.4 Israel Infectious Disease Drugs Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
10 Israel Infectious Disease Drugs Market - Competitive Landscape |
10.1 Israel Infectious Disease Drugs Market Revenue Share, By Companies, 2024 |
10.2 Israel Infectious Disease Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here